188 related articles for article (PubMed ID: 21216590)
21. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
[TBL] [Abstract][Full Text] [Related]
22. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results.
Elias DM; Ouellet JF
Surg Oncol Clin N Am; 2001 Oct; 10(4):915-33, xi. PubMed ID: 11641098
[TBL] [Abstract][Full Text] [Related]
23. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei: need to establish a multi-institutional registry.
Yan TD
Ann Surg; 2008 Mar; 247(3):556-7. PubMed ID: 18376211
[No Abstract] [Full Text] [Related]
25. An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis.
Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Jul; 14(7):2171-2. PubMed ID: 17453299
[No Abstract] [Full Text] [Related]
26. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.
Jess P; Iversen LH; Nielsen MB; Hansen F; Laurberg S; Rasmussen PC
Dis Colon Rectum; 2008 Jun; 51(6):868-74. PubMed ID: 18297361
[TBL] [Abstract][Full Text] [Related]
27. [Updated treatment of peritoneal carcinomas: a review].
Deraco M; Laterza B; Kusamura S; Baratti D
Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656
[TBL] [Abstract][Full Text] [Related]
28. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
29. Pseudomyxoma peritonei.
Witham G
Nurs Times; 2003 Sep 30-Oct 6; 99(39):30-2. PubMed ID: 14562659
[TBL] [Abstract][Full Text] [Related]
30. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.
Elias D; Gilly F; Quenet F; Bereder JM; Sidéris L; Mansvelt B; Lorimier G; Glehen O;
Eur J Surg Oncol; 2010 May; 36(5):456-62. PubMed ID: 20227231
[TBL] [Abstract][Full Text] [Related]
31. Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Moradi BN; Esquivel J
J Surg Oncol; 2009 Sep; 100(4):293-6. PubMed ID: 19697425
[TBL] [Abstract][Full Text] [Related]
32. [Three cases of Pseudomyxoma peritonei treated with intraperitoneal inoculation of cisplatin through an implantable port system].
Suzuki T; Umekita N; Inoue S; Miyamoto S; Maeshiro T; Awane Y
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1449-51. PubMed ID: 9703851
[TBL] [Abstract][Full Text] [Related]
33. Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects.
Di Carlo I; Pulvirenti E; Sparatore F; Toro A; Cordio S
Surg Oncol; 2007 Dec; 16 Suppl 1():S145-8. PubMed ID: 18023575
[TBL] [Abstract][Full Text] [Related]
34. Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
Sugarbaker PH
Ann Surg Oncol; 2008 Jun; 15(6):1800-1; author reply 1802-3. PubMed ID: 18196342
[No Abstract] [Full Text] [Related]
35. [Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute].
Zoetmulder FA; van der Vange N; Witkamp AJ; Kaag MM; Boot H; Beijnen JH
Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1863-8. PubMed ID: 10526600
[TBL] [Abstract][Full Text] [Related]
36. Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy.
González-Moreno S; Ortega-Pérez G; González-Bayón L
J Surg Oncol; 2009 Sep; 100(4):287-92. PubMed ID: 19697424
[TBL] [Abstract][Full Text] [Related]
37. Clinical results of cytoreduction and HIPEC in pseudomyxoma peritonei.
Lutton NJ; Moran BJ
Cancer Treat Res; 2007; 134():319-28. PubMed ID: 17633063
[No Abstract] [Full Text] [Related]
38. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
40. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
